Parametrica Management Ltd Invests $290,000 in Humana Inc. (NYSE:HUM)

Parametrica Management Ltd bought a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,145 shares of the insurance provider’s stock, valued at approximately $290,000.

Several other large investors also recently made changes to their positions in the business. FPC Investment Advisory Inc. bought a new stake in Humana during the fourth quarter worth approximately $27,000. Centricity Wealth Management LLC acquired a new stake in shares of Humana during the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA boosted its stake in shares of Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new position in shares of Humana in the 4th quarter worth $33,000. Finally, Atwood & Palmer Inc. raised its position in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 60 shares during the period. Institutional investors own 92.38% of the company’s stock.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. JPMorgan Chase & Co. decreased their price target on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research report on Tuesday, February 18th. StockNews.com downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, March 18th. Royal Bank of Canada reissued an “outperform” rating and set a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Barclays upped their price target on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Eighteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and a consensus price target of $285.68.

Humana Stock Up 0.7 %

Shares of Humana stock opened at $273.51 on Wednesday. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The stock has a market capitalization of $33.01 billion, a P/E ratio of 27.49, a PEG ratio of 2.05 and a beta of 0.57. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a 50 day moving average price of $270.83 and a two-hundred day moving average price of $275.00.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.29%. Humana’s payout ratio is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.